Loading clinical trials...
Loading clinical trials...
This study is a Randomized Controlled Trial, investigating the safety and efficacy of administration of ketamine as a potential treatment for depression.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of New South Wales
Collaborators
NCT07042217 · Unipolar Depression
NCT06371352 · Unipolar Depression, Bipolar Disorder
NCT05894980 · Unipolar Depression, Impulsive Behavior, and more
NCT03895658 · Unipolar Depression
NCT04370002 · Unipolar Depression
Brain & Mind Research Institute (BMRI), University of Sydney
Camperdown, New South Wales
Black Dog Institute, University of New South Wales
Sydney, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions